PlanExe: Turn your idea into a detailed plan
Executive summary, gantt, risks, swot, budget, premortem, and more.
How it works
Describe your idea
Enter a description of your project, from a startup pitch to a complex infrastructure project.
AI pipeline runs
PlanExe orchestrates 100+ LLM calls across legal, financial, and engineering review stages — cross-referencing, challenging, and stress-testing your plan.
Read your generated plan
Get a comprehensive report you can refine for investors, leadership, or internal planning.
Who is PlanExe for?
- Founders — Stress-test ideas early and avoid expensive mistakes.
- Project Managers — Standardize project kickoffs with structured, exportable plans.
- Developers — Connect PlanExe via MCP to tools like Claude, Cursor, and Codex.
AI that pushes back
Most AI tools just agree with you. PlanExe red-teams your plan to find flaws before you commit serious time or money.
Premise Attack
Deliberately argues that it's a bad idea. It doesn't matter how good your plan is — it will always argue against it.
Premortem Analysis
Imagines your project has already failed and works backwards to find out why.
Self-Audit
Cross-references experts across legal, financial, and engineering domains. Catches inconsistencies and contradictions.
Your plans stay yours
Unlike cloud-based alternatives, PlanExe can run fully offline on your own hardware. That means you can work on sensitive plans without sending them to external services.
Get started
PlanExe Cloud
Recommended way to try PlanExe. No setup. Type in your idea and read the generated plan.
PlanExe Account
Get your API keys to connect PlanExe's MCP server to Claude, Codex, Cursor, or Windsurf. Manage credits and view your generated plans.
PlanExe Local
100% private. Install and run PlanExe locally on your own hardware. Open source, MIT license.
Example plans
Cryosleep Program
Establish a 15-year, ¥18 billion Chinese national research program in reversible suspended metabolism, headquartered at a purpose-built campus within the Kunming Institute of Zoology, Chinese Academy of Sciences. The program’s primary objective is to develop the scientific foundations, protocols, medical devices, and implantable bioelectronic systems required to place mammals into prolonged metabolic suppression and revive them to functional health — with the explicit long-term goal of enabling human cryosleep for deep-space missions under CMSA oversight. The program acknowledges from the outset that full whole-body cryogenic preservation and revival may prove unachievable within this timeframe, and is therefore structured so that partial success — improved organ preservation, validated synthetic torpor protocols, implantable life-support devices, or safer rewarming methods — constitutes a transformative outcome in its own right with immediate applications in transplant medicine, battlefield trauma care, and critical care.
The program is organized into two parallel research tracks that converge in the later phases. Track A (Synthetic Torpor) focuses on pharmacologically induced metabolic suppression at near-cryogenic temperatures (10–15°C core body temperature), targeting days-to-months suspension duration where biological processes are slowed but not arrested, and where revival depends on controlled rewarming and metabolic restart. Track B (Deep Cryopreservation) focuses on vitrification-based preservation at cryogenic temperatures (below −80°C), targeting months-to-years suspension duration where biological activity is effectively halted, and where revival requires solving the qualitatively harder problems of uniform cryoprotectant perfusion, ice nucleation suppression, thermal stress management during rewarming, and organ-system revival sequencing. Each track has independent milestones and failure modes. The tracks converge at Tier 3, where the optimal suspension regime — torpor, vitrification, or a hybrid combining torpor-based induction with vitrification for long-duration maintenance — is selected based on empirical results, not predetermined.
A third parallel track, Track C (Implantable Cryosleep Life-Support), runs from year 3 onward and develops bioelectronic implant systems designed to maintain organ viability during suspension and assist revival. These include: micro-perfusion pumps that deliver localized cryoprotectant or metabolic support agents to vulnerable organs (brain, kidneys, heart) independent of systemic circulation; cardiac preservation pacemakers that maintain minimal electrical patterning in myocardial tissue to prevent structural degradation during prolonged arrest; embedded neural monitoring arrays that track brain activity signatures pre-, during, and post-suspension to provide real-time viability assessment; and localized rewarming implants that enable controlled, organ-specific thermal recovery to mitigate differential thermal stress during revival. These devices are designed from the start for dual use — spaceflight cryosleep integration and civilian medical application — and represent the program’s most likely near-term commercial output.
Organism tiers proceed within each track. Tier 1 (years 1–3, ¥1.5B) works with small hibernating mammals (Daurian ground squirrels, Djungarian hamsters) in Track A and small non-hibernators (rats) for early vitrification feasibility in Track B. Success criteria are pre-registered and specific: Track A requires 12-month torpor with post-revival performance on Morris water maze and novel object recognition within 85% of age-matched controls measured at 30, 90, and 180 days post-revival, with quantified hippocampal and cortical histopathology scoring. Track B requires successful vitrification and revival of individual organs (kidney, liver) with functional benchmarks (creatinine clearance, albumin synthesis) within 70% of pre-vitrification baseline. Tier 2 (years 3–6, ¥3.5B) scales Track A to non-hibernating mammals (rabbits, rats) and Track B to multi-organ vitrification in small mammals, with first integration of Track C prototype implants. Tier 3 (years 6–10, ¥5.5B) moves to large mammals (pigs) where Track A and B results inform the selection of the optimal suspension regime, and Track C implants are tested in vivo during prolonged suspension. Tier 4 (years 10–15, ¥7.5B) is contingent on Tier 3 achieving predefined gates — it proceeds to non-human primates only if large-mammal revival rates exceed 85% with cognitive and organ function within 90% of baseline on pre-registered endpoints. If Tier 3 gates are not met, Tier 4 budget redirects to iterating on the large-mammal protocol or advancing the most promising partial results. Tier 4 deliverables, if reached, include a draft human cryosleep protocol, a validated implant suite for organ-specific life support during suspension, a candidate cryoprotectant formulation, and a revival hardware package designed for spacecraft life-support integration.
The consortium is led by CAS with participation from the Institute of Zoology Beijing (hibernation biology), Yinfeng Life Science Research Institute in Jinan (cryopreservation engineering), the PLA General Hospital (hypothermic surgical medicine and implantable device trials), Zhejiang University (materials science for cryoprotectant and implant development), Tsinghua University (biomedical imaging and bioelectronics), and CMSA as an advisory stakeholder for spacecraft integration requirements. Governance includes an independent scientific advisory board with at least three international members from recognized cryobiology and bioethics institutions, transparent milestone gates with predefined stop conditions and welfare escalation triggers at each tier, and mandatory publication of all primary endpoints — including negative results and failed revival data — in international peer-reviewed journals within 18 months of collection. Data release timing for secondary and engineering datasets follows Chinese data governance requirements but the program commits to full dataset publication within 36 months.
Budget of ¥18 billion is funded through the National Key R&D Program, CAS strategic priority allocation, provincial co-funding from Yunnan and Shandong, CMSA crewed spaceflight development budget, and supplemental investment from state biotech and medical device funds. Personnel: approximately 500 FTE at peak spanning cryobiologists, perfusion engineers, veterinary surgeons, neuroscientists, materials scientists, bioelectronics engineers, aerospace life-support engineers, and program managers. A dedicated technology transfer office operates from year 4, with a mandate to license implant and cryoprotectant IP, incubate medical device spinoffs, and attract private capital — the implantable life-support devices in particular are expected to find immediate markets in organ transplant logistics, emergency medicine, and surgical hypothermia well before the cryosleep application matures. Pick a realistic, risk-aware scenario — the plan should explicitly model tier-gate failures, budget reallocation on partial success, and define the minimum viable scientific outcome if full long-duration revival proves impossible within the program window. Banned words: blockchain, VR, AR, metaverse, immortality.
Crate Recovery Campaign
Inspired by this press release about plastic waste.
Arla Foods, Denmark’s largest dairy cooperative, loses approximately 270,000 of its iconic green plastic milk crates every year because they never return from supermarket delivery routes — consumers repurpose them as storage boxes, garden furniture, playground building blocks, and countless other second lives. Each crate is engineered to last 20 years, so every unreturned unit represents wasted material and energy; the replacement production alone generates an estimated 106 tonnes of CO2 annually. Arla now wants to run a nationwide return campaign throughout 2026 to recover as many of these crates as possible, using a charitable donation as the behavioural nudge: for every green Arla crate handed back, the company will donate five Danish kroner to Arla Foundation, which funds children’s nutrition education programmes across Denmark.
The campaign’s return infrastructure spans two channels: consumers can drop off crates at participating supermarket chains (the same stores that receive Arla deliveries) and at Denmark’s network of municipal recycling stations (genbrugsstationer). Logistics must handle collection, inspection, cleaning, and reintroduction of returned crates into the existing dairy supply chain, while crates that are too damaged for reuse need to be routed to plastics recycling. The programme should define clear visual identification guidance so consumers can distinguish an Arla crate from look-alikes, and supermarkets need simple in-store procedures — signage, a designated drop-off point, and a lightweight count-and-report mechanism — without burdening staff or disrupting normal operations. Recycling stations need similar low-friction intake instructions.
Stakeholders include Arla Foods (programme owner and funder), Arla Foundation (donation recipient and co-communicator), major Danish supermarket groups such as Salling Group, Coop Danmark, and Rema 1000, municipal waste authorities operating the recycling stations, and the Danish public as participants. The campaign’s marketing should be provocative enough to cut through everyday noise — these crates are a culturally familiar object in Denmark, and the message should tap into that recognition with humour or surprise while emphasising both the environmental upside (CO2 reduction) and the charitable angle (children’s nutrition). Social media virality and earned press coverage are explicit goals; paid media should be supplementary rather than primary.
Budget is estimated at 5 DKK × up to 270,000 crate returns = 1.35 million DKK in maximum donation outlay, plus campaign marketing, logistics infrastructure, and supermarket coordination costs — assume a total programme budget ceiling of 4 million DKK. Timeline: campaign concept and logistics design by end of Q1 2026, pilot launch in select regions during Q2, and nationwide rollout from Q3 through end of 2026. Success criteria: recover at least 40% of the annual loss volume (108,000 crates) in year one, achieve measurable reduction in new-crate production orders for 2027, generate at least 20 million organic social media impressions, and donate a minimum of 500,000 DKK to Arla Foundation. Pick a realistic, low-risk scenario — this is a CSR-driven logistics campaign, not a moonshot. Banned words: blockchain, NFT, AI, VR, AR.
Secure low Earth orbit, remove debris
A 15-year, $20 billion initiative led by a consortium of space agencies including NASA, ESA, JAXA, and ISRO alongside commercial stakeholders, focused on securing the future of low Earth orbit by removing the 500 most critical debris threats. Capitalized by the coalition members, this program will deploy a suite of proven technologies—from robotic capture to precision laser mitigation—within a transparent framework addressing dual-use concerns and adhering strictly to applicable international laws. An independent risk-assessment model, overseen by the consortium, will guide target selection based on collision probability to verifiably reduce risk, protect vital satellite infrastructure, and establish a new paradigm for cooperative space governance among participating nations.
This initiative explicitly excludes Russia’s Roscosmos and China’s CNSA due to ongoing geopolitical conflicts and a lack of mutual trust, which make collaboration impossible at this time. While their participation would be ideal for a truly global effort, current political realities prevent their involvement. The coalition remains open to expanding cooperation if and when these conditions change.
Get involved
Introduce yourself on the PlanExe Discord and ask how you can help.
- Python Developer: Tweak the core engine, DAG pipelines, and agent prompts.
- Prompt Engineer: Refine the system prompts for better expert responses and red-teaming.
- Project Manager: Provide feedback on missing project methodologies or export formats.
- Designer: Enhance the HTML report UI and interactive data visualizations.